US Edition
How Funding Cuts Are Undermining Patient Recruitment In Clinical Trials - Data Intelligence
Summary by Plato. Vertical Search. Ai. | PlatoAiStream. Data Intelligence. Vertical Search. Ai.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Pharma Pulse 7/1/25: Oncology Care Index Spurs J&J to Address Fragmentation in Cancer Treatment; How Funding Cuts Are Undermining Patient Recruitment in Clinical Trials
Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.
How Funding Cuts Are Undermining Patient Recruitment In Clinical Trials - Data Intelligence
In a recent video interview with Applied Clinical Trials, Kyle McAllister, co-founder, CEO, Trially, discussed the impact of funding cuts on underrepresented populations in medical research, emphasizing the importance of diversity-focused research. He highlighted the challenges created by budget cuts, particularly in patient recruitment and retention, due to reduced support staff. McAllister noted that artificial intelligence (AI) and new techno…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
